Posts

Showing posts with the label Epstein-Barr Virus Infection market forecast

Epstein-Barr Virus Infection – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Epstein-Barr virus (EBV) is a double-stranded DNA virus within the herpesvirus family that primarily infects B lymphocytes. Transmission of EBV occurs through various means, including deep kissing, sharing food, stem cell and organ transplantation, and blood transfusion. Following initial infection, elevated levels of viral DNA are present in salivary secretions. Children can contract the virus by consuming food pre-chewed by an infected individual. The symptomatic presentation of EBV infection includes fatigue, fever, inflamed throat, swollen lymph nodes in the neck, enlarged spleen, swollen liver, and rash. Primary infection targets the epithelial cells of the oropharynx and parotid gland, with viral shedding continuing for weeks to months post-infection. After replicating in epithelial cells, EBV infects B cells and rapidly establishes latency. Latent EBV  is implicated  in the etiology of nasopharyngeal carcinoma, Burkitt's lymphoma, and other lymphoproliferative ...